These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 3829013

  • 21. Anti-tumor activity of daunorubicin linked to poly-L-aspartic acid.
    Zunino F, Giuliani F, Savi G, Dasdia T, Gambetta R.
    Int J Cancer; 1982 Oct 15; 30(4):465-70. PubMed ID: 7141741
    [Abstract] [Full Text] [Related]

  • 22. Immunomodulation and antitumor effects of MVE-2 in mice.
    Talmadge JE, Maluish AE, Collins M, Schneider M, Herberman RB, Oldham RK, Wiltrout RH.
    J Biol Response Mod; 1984 Dec 15; 3(6):634-52. PubMed ID: 6334720
    [Abstract] [Full Text] [Related]

  • 23. Antitumor activity of tumor necrosis factor alpha conjugated with divinyl ether and maleic anhydride copolymer on solid tumors in mice.
    Kaneda Y, Yamamoto Y, Kamada H, Tsunoda S, Tsutsumi Y, Hirano T, Mayumi T.
    Cancer Res; 1998 Jan 15; 58(2):290-5. PubMed ID: 9443407
    [Abstract] [Full Text] [Related]

  • 24. Experimental evaluation of anthracycline analogs.
    Casazza AM.
    Cancer Treat Rep; 1979 May 15; 63(5):835-44. PubMed ID: 455325
    [Abstract] [Full Text] [Related]

  • 25. Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function.
    Pavlidis NA, Schultz RM, Chirigos MA, Luetzeler J.
    Cancer Treat Rep; 1978 Nov 15; 62(11):1817-22. PubMed ID: 728899
    [Abstract] [Full Text] [Related]

  • 26. Modulation of doxorubicin efficacy in P388 leukemia following co-administration of verapamil in mini-osmotic pumps.
    Slate DL, Fraser-Smith EB, Rosete JD, Freitas VR, Kim YN, Casey SM.
    In Vivo; 1993 Nov 15; 7(6A):519-23. PubMed ID: 8193270
    [Abstract] [Full Text] [Related]

  • 27. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V, Grazeliene G, Dabkeviciene D, Micke I, Kirvelis D, Juodka B, Didziapetriene J.
    Cancer Chemother Pharmacol; 2006 Jan 15; 57(1):65-72. PubMed ID: 16001168
    [Abstract] [Full Text] [Related]

  • 28. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, Ford J, Wu G, Kneller S, Davies J, Duncan R.
    Bioconjug Chem; 2005 Jan 15; 16(4):775-84. PubMed ID: 16029018
    [Abstract] [Full Text] [Related]

  • 29. Response of murine leukemia to combined BCNU-maleic anhydride-vinyl ether (MVE) adjuvant therapy and correlation with macrophage activation by MVE in the in vitro growth inhibition assay.
    Dean JH, Padarathsingh ML, Keys L.
    Cancer Treat Rep; 1978 Nov 15; 62(11):1807-16. PubMed ID: 728898
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis, antitumor activity, and cardiac toxicity of new 4-demethoxyanthracyclines.
    Penco S, Casazza AM, Franchi G, Barbieri B, Bellini O, Podestà A, Savi G, Pratesi G, Geroni C, Di Marco A, Arcamone F.
    Cancer Treat Rep; 1983 Nov 15; 67(7-8):665-73. PubMed ID: 6575865
    [Abstract] [Full Text] [Related]

  • 31. The antineoplastic activity of 4'-deoxydoxorubicin in murine solid tumors.
    Marmonti L, Jin XQ, Filippeschi S, Spreafico F.
    Anticancer Res; 1984 Nov 15; 4(6):425-9. PubMed ID: 6517535
    [Abstract] [Full Text] [Related]

  • 32. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL, Rauth AM, Bendayan R, Wu XY.
    Eur J Pharm Biopharm; 2007 Mar 15; 65(3):300-8. PubMed ID: 17156986
    [Abstract] [Full Text] [Related]

  • 33. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM, Erickson LC, Ringsdorf H, Zaharko DS.
    Cancer Res; 1980 Oct 15; 40(10):3704-8. PubMed ID: 7438053
    [Abstract] [Full Text] [Related]

  • 34. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM.
    Cancer Res; 1983 Jun 15; 43(6):2880-3. PubMed ID: 6573953
    [Abstract] [Full Text] [Related]

  • 35. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma.
    Yuan X, Tabassi K, Williams JA.
    Radiat Oncol Investig; 1999 Jun 15; 7(4):218-30. PubMed ID: 10492162
    [Abstract] [Full Text] [Related]

  • 36. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
    Pratesi G, Casazza AM, Di Marco A.
    Cancer Treat Rep; 1978 Jan 15; 62(1):105-10. PubMed ID: 626988
    [Abstract] [Full Text] [Related]

  • 37. Distribution and antitumor activity of adriamycin given in a high-dose and a repeated low-dose schedule to mice.
    Pacciarini MA, Barbieri B, Colombo T, Broggini M, Garattini S, Donelli MG.
    Cancer Treat Rep; 1978 May 15; 62(5):791-800. PubMed ID: 657163
    [Abstract] [Full Text] [Related]

  • 38. Antitumor activity and toxicity in animals of RR-150 (7-cysteaminomitosane), a new mitomycin derivative.
    Bradner WT, Rose WC, Schurig JE, Schlein A, Huftalen JB.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5619-23. PubMed ID: 6437670
    [Abstract] [Full Text] [Related]

  • 39. Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.
    Hisamatsu T, Suzuki K, Sakakibara S, Komuro K, Nagasawa M, Takeuchi T, Umezawa H.
    Jpn J Cancer Res; 1985 Oct 15; 76(10):1008-20. PubMed ID: 3935619
    [Abstract] [Full Text] [Related]

  • 40. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
    Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Oct 15; 44(10):4303-7. PubMed ID: 6467192
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.